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ABSTRACT
Introduction: This article aims to evaluate the
role of phakic intraocular lens (pIOL) implants
in the treatment of high-refractive errors and
amblyopia in the pediatric setting.
Methods: A literature search of the PubMed
database was conducted in December 2012
using the keywords: pIOL implants, amblyopia,
pediatric refractive surgery and ametropia, and
articles of high or medium clinical relevance
were selected for review. Inclusion criteria were
children aged 0–17 years who had undergone
pIOL implantation for the treatment of
refractive errors and/or amblyopia.
Results: Multiple studies have shown the
relevancy and effectiveness of pIOL implantation
as an alternative surgical management for highly
significant pediatric ametropia in selective
patients who are noncompliant with medical
treatment.
Conclusions: In the management of clinically
significant severe pediatric ametropic and/or
anisometropic myopia or hyperopia and in the
event of nonadherence to traditional medical
treatment, phakic anterior chamber IOL
implantation is currently considered an
effective modality of treatment. Long-term
follow-up of pediatric patients following pIOL
implantation is necessary. Future clinical trials
are needed to address the safety and efficacy of
the type of and the best time for pIOL
implantation in treatment and/or prevention
of amblyopia in children.
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INTRODUCTION
Refractive surgery in children is controversial.
Most children with refractive errors can be
treated adequately and safely with spectacles
or contact lenses, along with conventional
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therapy for amblyopia. However, in specific
subpopulations of children, intervention may
be necessary to achieve full visual function and
prevent amblyopia. Procedures employed in
pediatric refractive surgery include laser
keratorefractive procedures and intraocular
procedures such as phakic intraocular lens
(pIOL) implantation or clear lens extraction.
There is an abundance of literature
demonstrating the efficacy and safety of pIOLs
in the adult population [1, 2]. In children,
however, there is less evidence to support their
use. This article aims to review the evidence for
pIOLs in the treatment of high-refractive errors
and amblyopia in the pediatric population.
Indication for pIOLs in Children
Most children with refractive errors can be
treated adequately and safely with spectacles or
contact lenses, along with conventional therapy
for amblyopia. However, in certain subsets of
children, traditional treatment is ineffective and
further intervention is necessary. Currently,
refractive surgery in children is performed only
when conventional treatments have failed. In
children with high-refractive errors, spectacle
tolerance can be reduced secondary to prismatic
induced aberrations, limited field of view, as
well as cosmetic appearance. Contact lenses can
also be problematic in children due to difficulty
with insertion and removal, infection,
intolerance and expense.
The particular pediatric subpopulations that
may require refractive surgery include those
with bilateral significant ametropia or
anisometropia who are spectacle or contact
lens noncompliant, as well as those with
secondary high-refractive amblyopia in
children with neurobehavioral disorders
(Table 1).
pIOL Implants
pIOLs are available in three models, iris-fixated
anterior chamber, ciliary sulcus-supported
posterior chamber, or angle-supported anterior
chamber. The preference currently appears to be
for iris-fixated anterior chamber IOLs [3]. The
first pIOL implanted in a child was carried out
in 1998 by Lesueur and Arne [4], a posterior
chamber pIOL (PC-pIOL) was successfully
implanted in five children (aged 3–16 years)
with high anisometropic myopia who were
noncompliant with spectacles or contact
lenses. Following the positive outcome of this
study, further studies were undertaken using
both anterior and PC-pIOLs to restore
emmetropia [3–5, 9–15], with the aim of
treating refractive-induced amblyopia.
PC-pIOL
Lesueur and Arne [4] reported results of
PC-pIOL insertion in five eyes of children aged
3–16 years old with amblyopic high myopia and
a mean preoperative spherical equivalent of
-12.8 D. There were no complications reported
from the study, and all parents reported an
improvement in their child’s quality of life.
A gain of 3 or more Snellen lines, as well as
recovery of binocular vision was observed in
two patients. A follow-up study by Lesueur and
Table 1 Indications for phakic intraocular lens
implantation in children
1. High anisometropia, myopia, or hyperopia
noncompliant with conventional treatment
2. Bilateral high ametropia noncompliant with
conventional treatment
3. Secondary high-refractive amblyopia associated
with neurobehavioral disorders
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Arne [5] reported outcomes of PC-pIOL to
correct high myopia and amblyopia in 12 eyes
of children aged 3–16 years old. These children
had a mean preoperative spherical equivalent of
-12.7 D and were followed up for a period of
20.5 months. Six patients recovered binocular
vision and showed improvement in QOL. There
were no reported complications.
BenEzra et al. [6] implanted PC-pIOLs in
three children (aged 9–18 years) with
anisometropic amblyopia and myopia of -6
to -16 D. Follow-up over a 9-month period
showed significant improvement in visual
acuity and binocular function. No change in
endothelial cell count was observed over the
9-month follow-up period.
Alio et al. report the longest follow-up period
of 5 years, following PC-pIOL implantation in a
child with high anisometropic amblyopia.
Improvement in visual acuity of one logMAR
line was reported, and no complications were
seen [7].
Potential complications of PC-pIOLs include
cataract formation, pupillary block glaucoma,
posterior dislocation into the vitreous cavity,
and retinal detachment [8]. Reports of
complications in the pediatric population are
rare; however, this is likely due to the low
overall numbers of PC-pIOLs in children.
Anterior Chamber Iris–Claw pIOL
The iris–claw anterior chamber IOL, designed by
Jan Worst, was first implanted in the adult
population in 1978 to correct aphakia following
cataract surgery. In 1986, this design was altered
to a biconcave polymethyl-methacrylate optic
with an overall length of 8.5 mm, and the IOL
was implanted in the first sighted myopic eye
[9]. The design was further modified in 1991 to
a convex–concave IOL, and in 1998, the name
of the lens was changed to Artisan (Ophtec
B.V., Groningen, The Netherlands) and
VerisyseTM (Abbott Medical Optics, Abbott
Laboratories Inc. Abbott Park, IL, USA). The
iris–claw IOL was first used in children in 1997
to correct aphakia in a series of 27 children (38
eyes) [10].
Table 2 Pediatric anterior chamber phakic intraocular lens studies
Author Eyes Indication Age Follow-up
Chipont et al. [11] 1 Unilateral high myopia 8 18 months
Saxena et al. [12] 1 Unilateral high myopia 4 3 years
Lifshitz and Levy [13] 1 Unilateral high myopia (PC-pIOL) 3 9 months
Assil et al. [15] 1 Unilateral high myopia 3 4 years
Tychsen et al. [16] 20 Bilateral high ametropia (16 eyes) and high
anisometropia (4 eyes) in neurobehavioral disorders
4–17 3–15 months
Pirouzian and Ip [14] 7 Unilateral high myopia 5–11 3 years
Alio et al. [7] 10 High anisometropia and amblyopia 2–15 5 years
Ryan et al. [17] 11 High bilateral myopia in neurobehavioral
disorders, high anisometropia
8–15 15 months
Total 51 39 childrens 2–17 3 months–5 years
Data from [7, 11–17]
PC-pIOL posterior chamber phakic intraocular lens
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Studies on pediatric anterior chamber pIOL
are shown in Table 2 [7, 11–17]. The use of
iris–claw anterior chamber IOLs expanded to
treatment of anisometropic amblyopia in
children when Chipont et al. [11] implanted
an Artisan pIOL in an 8-year-old child,
achieving a corrected visual acuity of 20/25
which was stable at 18-month follow-up. No
complications were reported. Saxena et al. [12]
showed an improvement of visual acuity to
20/20 in a 4-year-old child with Artisan pIOL
implantation for high myopic anisometropia.
A significant rate of 11.9% endothelial cell loss
was observed. Lifshitz and Levy [13] observed
positive results of improved visual acuity
following implantation of Artisan pIOL in a
14-month-old pseudophakic child over a
9-month follow-up period. Pirouzian and Ip
[14] implanted iris-fixated pIOLs in seven
children with anisometropic myopia and
amblyopia. Three-year results showed
improvement in visual acuity of more than six
lines in all patients and no postoperative
complications were reported. Assil et al. [15]
reported positive 4-year follow-up results in
3 years old with myopic anisometropia.
Tychsen et al. [16] reported a larger series of
pIOLs in 12 children with neurobehavioral
disorders and high ametropia, and found that
visual function was substantially improved by
an average of 73% in bilateral ametropic
patients and 58% in anisometropic patients.
Ryan et al. [17] observed a significant
improvement in vision and vision-related QOL
in 11 eyes of six children implanted with
Artiflex (Ophtec B.V., Groningen, The
Netherlands) pIOL for high bilateral myopia
and concurrent neurobehavioral disorders, high
anisometropia, or high myopic astigmatism.
There were no intraoperative or postoperative
complications observed. Five-year follow-up of
nine children implanted with iris-fixated pIOL
for anisometropic amblyopia was reported by
Alio et al. [7]. Improvement of more than three
logMAR lines of corrected visual acuity was seen
in all nine children. Endothelial cell count at
5 years postoperatively was[2,000 cells/mm2 in
80% of patients; for the remaining patients, eye
rubbing and ocular trauma was a factor in
endothelial cell loss.
DISCUSSION
Management of pediatric high bilateral
ametropia and anisometropia is challenging.
In cases where spectacle or contact lens
correction is not tolerated, the child is at risk
of secondary high-refractive amblyopia.
Management options in such cases include
corneal laser ablative procedures, refractive
lens exchange, and pIOL insertion.
The advantages of pIOLs are numerous
(Table 3). With pIOLs, the surgeon is capable
of treating a much larger range of refractive
errors than can be safely treated with corneal
refractive surgery, and natural accommodation
is preserved. The skills required for insertion are
Table 3 Advantages of phakic intraocular lenses
1. Reversibility and ability to exchange IOL
2. Predictability
3. High visual quality
4. Quick visual rehabilitation
5. Preservation of accommodation
6. Preservation of corneal surface—option of bioptics
7. Lack of regression
8. No special operating room requirements
9. Can be performed by nonrefractive surgeons
10. Retinal magniﬁcation in myopic eyes—potential gain
of vision
IOL intraocular lens
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similar to those required for cataract surgery,
and the equipment is significantly less
expensive. In comparison, corneal laser
ablation carries the disadvantage of corneal
haze and high rate of refractive regression with
photorefractive keratectomy; particularly as
large refractive errors are being treated [18,
19]. LASIK is technically difficult in children,
requires general anesthesia, and has the risk of
long-term ectasia. Traumatically induced
displacement of a LASIK flap is a serious and
sight-threatening complication, which children
are inherently at high risk of given the nature of
children’s behavior and activities. Refractive
lens exchange results in an increased risk of
retinal detachment, glaucoma, and posterior
capsule opacification, as well as loss of
accommodation [20].
The implant of choice for pediatric patients
is the anterior chamber Artisan iris-fixated pIOL
(Figs. 1, 2), although the foldable Artiflex model
which requires a smaller incision and less
corneal sutures has been shown to be safe and
effective also [17]. Safe insertion and lower
long-term risk for endothelial cell loss requires
an anterior chamber depth of 3.2 mm or
greater. This may preclude the use of iris-
fixated pIOLs in children younger than
3 years, and children with shallow anterior
chambers, as can occur in children with high
myopia following retinopathy of prematurity.
An iridotomy or iridectomy must be performed
during the procedure to reduce chances of
pupillary block. In cases of high bilateral
ametropia, the eyes are usually implanted
sequentially, about 1 month apart. Absorbable
sutures are used to avoid re-anesthetizing the
child for suture removal.
On review of the published literature, the
results show that pIOLs are an effective option
in pediatric patients to improve visual acuity
and prevent amblyopia. The visual outcome in
these patients cannot be compared with the
standard IOL patient due to the underlying
pathologies. Lack of 20/20 vision is usually a
result of numerous factors such as intractable
amblyopia, optic nerve disorders, retinopathies,
or foveopathies.
Reports of adverse events in the pediatric
population are rare due to the limited number
of surgeries performed; however, complications
in adults include cataract formation, uveitis,
IOL dislocation, pigment dispersion, and
Fig. 1 Child with bilateral iris-ﬁxated anterior chamber
phakic intraocular lens
Fig. 2 Artiﬂex iris-ﬁxated phakic intraocular lens in situ
Table 4 Complications of phakic intraocular lenses




5. Shallow anterior chamber
Ophthalmol Ther (2013) 2:3–9 7
123
endothelial cell loss (Table 4). The most
significant concern in the pediatric population
is long-term corneal endothelial cell loss. This is
particularly important given the long life
expectancy of the child, as well as potential
for eye rubbing. However, experience in the
pediatric population to date is limited and this
is compounded by difficulties in obtaining
accurate endothelial cell counts in children. In
the studies of Pirouzian and Ip [14] and Alio
et al. [7], the endothelial cell loss rate varied
over the course of 3–5 years between 6.5% and
15.2%.
CONCLUSION
Early intervention is necessary in a small subset
of the pediatric population with high
anisometropia, high bilateral ametropia, or
secondary high-refractive amblyopia who are
noncompliant with traditional therapy. Careful
patient selection and follow-up are essential
and further studies are necessary to determine
the long-term safety in the pediatric
population. pIOLs have been shown to
improve visual acuity and vision-related
quality of life in children, and plays an
increasingly important role in the treatment of
high-refractive errors and amblyopia.
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